Found: 2
Select item for more details and to access through your institution.
Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration Beyond One Year of Treatment: AZURE, a Randomized Trial of Treat-and-Extend vs. Fixed Dosing.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 3, p. 1010, doi. 10.1007/s12325-023-02719-3
- By:
- Publication type:
- Article
Dosing Regimens of Intravitreal Aflibercept for Diabetic Macular Edema Beyond the First Year: VIOLET, a Prospective Randomized Trial.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 2701, doi. 10.1007/s12325-022-02119-z
- By:
- Publication type:
- Article